| Literature DB >> 30283034 |
Igor Zwir1,2, Javier Arnedo2, Coral Del-Val2, Laura Pulkki-Råback3, Bettina Konte4, Sarah S Yang5, Rocio Romero-Zaliz2, Mirka Hintsanen6, Kevin M Cloninger7, Danilo Garcia8,9, Dragan M Svrakic1, Sandor Rozsa1, Maribel Martinez1, Leo-Pekka Lyytikäinen10, Ina Giegling4,11, Mika Kähönen12, Helena Hernandez-Cuervo13, Ilkka Seppälä10, Emma Raitoharju10, Gabriel A de Erausquin14, Olli Raitakari15, Dan Rujescu4, Teodor T Postolache16,17, Joohon Sung5, Liisa Keltikangas-Järvinen3, Terho Lehtimäki10, C Robert Cloninger18,19.
Abstract
Human personality is 30-60% heritable according to twin and adoption studies. Hundreds of genetic variants are expected to influence its complex development, but few have been identified. We used a machine learning method for genome-wide association studies (GWAS) to uncover complex genotypic-phenotypic networks and environmental interactions. The Temperament and Character Inventory (TCI) measured the self-regulatory components of personality critical for health (i.e., the character traits of self-directedness, cooperativeness, and self-transcendence). In a discovery sample of 2149 healthy Finns, we identified sets of single-nucleotide polymorphisms (SNPs) that cluster within particular individuals (i.e., SNP sets) regardless of phenotype. Second, we identified five clusters of people with distinct profiles of character traits regardless of genotype. Third, we found 42 SNP sets that identified 727 gene loci and were significantly associated with one or more of the character profiles. Each character profile was related to different SNP sets with distinct molecular processes and neuronal functions. Environmental influences measured in childhood and adulthood had small but significant effects. We confirmed the replicability of 95% of the 42 SNP sets in healthy Korean and German samples, as well as their associations with character. The identified SNPs explained nearly all the heritability expected for character in each sample (50 to 58%). We conclude that self-regulatory personality traits are strongly influenced by organized interactions among more than 700 genes despite variable cultures and environments. These gene sets modulate specific molecular processes in brain for intentional goal-setting, self-reflection, empathy, and episodic learning and memory.Entities:
Mesh:
Year: 2018 PMID: 30283034 PMCID: PMC7515844 DOI: 10.1038/s41380-018-0263-6
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 13.437
Fig. 1a Two examples of SNP sets are represented as heatmap submatrices or biclusters. SNP sets were identified by distinct patterns of molecular features of SNPs in subgroups of subjects. Allele values are indicated as BB (dark blue), AB (intermediate blue), AA (light blue), and missing (black). SNP sets were labeled for specificity by a pair of numbers representing the maximum number of clusters from which the bicluster was selected (e.g., 33 clusters may produce more specific than 21) and the order in which they were selected by the method (e.g., 4th bicluster or factor selected by FNMF when the maximum number of clusters was 21) and usually have a prefix G for genotype or P for phenotype. Only a subset of optimal and cohesive sets are selected across all number of clusters (See Supplementary Methods). The SNPs within each SNP set can map to different chromosomes (e.g., 6 and 8) and exhibit distinct molecular consequences (see Supplementary Table S3). The pie chart shows the percentage of SNPs within a SNP set that belong to each type of consequence. b Dissection of a GWAS in a Finnish population to identify the genotypic and phenotypic architecture of personality measured by the TCI. The genotypic network is depicted as nodes (SNP sets) linked by shared SNPs (blue lines) and/or subjects (red lines) (see also Supplementary Figure S3A for additional subnetworks). Each SNP set maps to one or more genes (see Supplementary Table S6 for full list of genes associated with each SNP set). SNP sets associated with each of the five general character profiles are distinguished by color-coding as shown in the legend (see Table 3). c, d Comparison of level of ill-being (c where high values indicate ill-being) and for level of well-being (d where high values indicate well-being) in groups of subjects with each of the five character profiles specified by both phenotypic and genotypic information (evaluated by ANOVA). (Compare with either genetic or phenotypic assessment alone in Supplementary Figure S6). e Variation in health status of SNP sets: well (blue, see d), ill (orange, see c), intermediate (gray). f 12 genotypic-phenotypic pipelines connect different sets of genes to the same character dimension (see also Supplementary Tables S9–S12). Red lines indicate direct connections, whereas blue lines and “&” indicate composite connections. g Surface showing the pattern of health status of the subjects in this study based on SNP set information only (i.e., interpolation from Table 1). The probability of well-being in the z-axis varies from high (red for high well-being) to low (green). The order of the SNP sets is based on shared subjects (x-axis) and on shared SNPs (y-axis) measured by hypergeometric statistics, so SNP sets sharing more SNPs and/or subjects are nearby (see ill health surface in Supplementary Figure S4). h Surface showing the pattern of health status of subjects based on both genotypic information (SNP sets) and phenotypic information (character sets) (as in Table 3). The probability of well-being in the z-axis varies from high (red, high well-being) to low (green). The sharing of subjects is shown for both SNP sets (x-axis) and character sets (y-axis) (see ill health surface in Supplementary Figure S5)
Fig. 2a, b Types of genetic variants mapped by SNP sets associated with character: a Specific molecular consequences (Supplementary Table S5) and b their subtypes. Genes related only to character sets (red) were less often protein coding and more often RNA genes than those also associated with temperament sets (blue color). c Cell displaying the molecular pathways containing genes associated only with the organized profile. The uncovered genes influence the phosphatidyl inositol/calcium second-messenger signaling system that regulates the seeking of food and other goals in response to external environmental signals (see also Supplementary Tables S4, S7). d Multiple SNPs within a SNP set can affect a single or multiple genes in many ways (Supplementary Table S3). Within the MTA3 gene, SNPs in the SNP set G_12_1 may affect both coding and regulatory regions (thereby inhibiting transcription), whereas SNPs from SNP set 40_26 are mostly located in intronic regions (thereby blocking or decreasing protein production). The SNP sets are associated with profiles exhibiting distinct character features (creative vs. apathetic)
Description of 42 SNP sets associated with character sets (p < 1E-05)
| Finnish sample | Probability of health | aGenes | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SNP sets | SNP-set name | % Coding | SKAT | Best SNP | Average SNPs | aSubjects | aSNPs | Well-being | Ill-being | |
| G_3_1 | Inositol-calcium signaling* | 62 | 2.88E-102 | 3.01E-05 | 2.64E-01 | 311 | 2163 | 0.06 | 0.1 | >300 |
| G_8_8 | Inositol/chemokine pathways | 67 | 2.21E-55 | 8.55E-05 | 1.99E-01 | 224 | 611 | 0.08 | 0.07 | 291 |
| G_7_2 | GPCR dysregulation | 62 | 2.07E-31 | 9.00E-05 | 2.44E-01 | 211 | 303 | 0.09 | 0.23 | 142 |
| G_7_3 | Neurogenesis | 63 | 1.67E-20 | 1.07E-04 | 1.85E-01 | 133 | 364 | 0.17 | 0.36 | 136 |
| G_11_4 | Inositol signaling | 55 | 1.22E-19 | 9.00E-05 | 3.29E-02 | 141 | 172 | 0.07 | 0.04 | 51 |
| G_12_8 | Neuroprotection | 62 | 1.49E-16 | 2.53E-04 | 3.39E-01 | 173 | 285 | 0.09 | 0.03 | 111 |
| G_7_7 | Olfaction | 56 | 1.32E-11 | 3.27E-05 | 2.25E-01 | 145 | 193 | 0.03 | 0.1 | 55 |
| G_36_29 | Electron transport | 50 | 5.37E-09 | 4.27E-04 | 3.37E-01 | 25 | 185 | 0.08 | 0.48 | 76 |
| G_31_8 | Neurotrophin | 55 | 1.15E-08 | 2.90E-05 | 3.13E-01 | 54 | 183 | 0.09 | 0.54 | 64 |
| G_28_15 | Histone methylation | 44 | 2.77E-08 | 3.76E-05 | 2.23E-01 | 101 | 123 | 0.08 | 0.38 | 34 |
| G_9_8 | Neuroregulation | 57 | 3.82E-08 | 1.11E-04 | 3.48E-01 | 209 | 230 | 0.17 | 0.12 | 77 |
| G_24_6 | GFI1-neurite outgrowth | 36 | 5.22E-08 | 2.65E-04 | 7.47E-02 | 72 | 63 | 0.1 | 0.08 | 14 |
| G_19_5 | DARPP320-neuroplasticity | 30 | 8.31E-08 | 1.23E-04 | 2.13E-01 | 86 | 59 | 0.16 | 0.22 | 10 |
| G_33_15 | ERK-neurodevelopment | 53 | 1.60E-07 | 4.47E-04 | 8.47E-02 | 26 | 67 | 0.27 | 0.23 | 19 |
| G_23_2 | Biogenic amine synthesis | 50 | 2.24E-07 | 1.39E-04 | 9.46E-02 | 42 | 56 | 0.05 | 0.29 | 8 |
| G_3_2 | PAK-neuroprotection | 63 | 3.08E-07 | 1.70E-05 | 1.80E-01 | 133 | 197 | 0.18 | 0.24 | 35 |
| G_22_6 | Blood–brain barrier | 59 | 3.37E-07 | 2.53E-04 | 2.35E-01 | 37 | 93 | 0.08 | 0.16 | 32 |
| G_34_13 | CREB-episodic learning | 54 | 3.88E-07 | 2.38E-04 | 1.28E-01 | 41 | 49 | 0.05 | 0.29 | 13 |
| G_40_26 | Dopamine-feedback | 65 | 6.08E-07 | 3.88E-04 | 2.61E-01 | 39 | 98 | 0.08 | 0.36 | 17 |
| G_21_3 | Cellular senescence | 62 | 1.12E-06 | 1.85E-04 | 3.55E-01 | 60 | 117 | 0.1 | 0.23 | 34 |
| G_20_2 | Enhanced memory | 79 | 1.59E-06 | 2.78E-04 | 2.34E-01 | 25 | 80 | 0.24 | 0.12 | 19 |
| G_28_11 | Sensory transduction | 44 | 2.07E-06 | 8.29E-04 | 2.71E-01 | 32 | 81 | 0.22 | 0.06 | 9 |
| G_12_1 | Episodic learning | 61 | 5.06E-06 | 9.00E-05 | 3.41E-01 | 146 | 189 | 0.2 | 0.06 | 66 |
| G_41_33 | GPCR neuroplasticity | 40 | 5.31E-06 | 4.91E-04 | 2.71E-01 | 56 | 76 | 0.11 | 0.21 | 15 |
| G_9_3 | Pyrimidine metabolism | 50 | 6.03E-06 | 4.54E-05 | 2.55E-02 | 164 | 35 | 0.12 | 0.04 | 6 |
| G_26_14 | Glucose transport | 59 | 6.98E-06 | 1.08E-04 | 2.20E-01 | 46 | 75 | 0.09 | 0.24 | 27 |
| G_20_3 | Fatty acid oxidation | 48 | 8.03E-06 | 2.07E-04 | 3.04E-01 | 36 | 82 | 0.03 | 0.33 | 21 |
| G_23_19 | Org2-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 87 | 32 | 0.08 | 0.03 | 4 |
| G_17_14 | Dep-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 47 | 32 | 0.09 | 0.15 | 4 |
| G_27_25 | Org3-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 54 | 32 | 0.11 | 0.07 | 4 |
| G_41_40 | Apath-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 34 | 32 | 0.09 | 0.03 | 4 |
| G_38_10 | Org5-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 27 | 32 | 0.15 | 0.19 | 4 |
| G_33_19 | Res-RNA | 0 | 1.17E-05 | 3.76E-05 | 9.37E-04 | 43 | 32 | 0.09 | 0.12 | 4 |
| G_21_4 | Org1-RNA | 0 | 1.28E-05 | 3.76E-05 | 9.41E-02 | 68 | 43 | 0.07 | 0.07 | 4 |
| G_10_1 | Learning/memory | 47 | 1.29E-05 | 3.27E-05 | 7.44E-02 | 131 | 48 | 0.07 | 0.06 | 15 |
| G_35_12 | Org4-RNA | 0 | 1.33E-05 | 3.76E-05 | 9.32E-04 | 45 | 31 | 0.16 | 0.09 | 3 |
| G_35_4 | O-linked glycosylation | 57 | 1.39E-05 | 3.74E-04 | 2.83E-01 | 42 | 37 | 0.05 | 0.24 | 7 |
| G_5_1 | CDK neuroplasticity | 100 | 1.78E-05 | 1.70E-05 | 5.60E-02 | 100 | 91 | 0.17 | 0.4 | 1 |
| G_19_9 | Aurora-B | 38 | 1.91E-05 | 2.65E-04 | 1.25E-01 | 20 | 46 | 0.1 | 0.4 | 8 |
| G_36_27 | Aging regulation | 25 | 1.96E-05 | 8.29E-04 | 1.60E-01 | 27 | 57 | 0.33 | 0.22 | 4 |
| G_16_9 | Olfactory signaling | 58 | 2.00E-05 | 2.31E-04 | 1.79E-01 | 64 | 36 | 0.08 | 0.17 | 12 |
| G_33_11 | Self-control | 50 | 3.67E-05 | 2.65E-04 | 9.39E-02 | 43 | 32 | 0.26 | 0.07 | 15 |
The SNP sets are named based on molecular pathways and neuronal functions of the genes that distinguish the sets from one another (see Supplementary Table S4). Percentage coding indicates the percentage of protein coding genes. Strengths of association are compared for the SNP set, the best SNP, and average SNP based on SKAT p-values. The number of subjects and SNPs comprising each SNP set is specified. The probabilities of the well-being and ill-being are given for subjects in each SNP set (see also Supplementary Table S2)
aGenes indicates the genes mapped by the SNP set (Figure S6), where genes can be mapped by more than one SNP set
The strength of the genotypic–phenotypic relationships among SNP and character sets and their corresponding health measurements
| Character sets | Character consensus sets | SNP sets | SNP-set names | Hypergeo-metric C-G | Health measurements of subjects | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Char sets | SNP sets | Both Sets Jointly | ||||||||
| Well-being | Ill-being | Well-being | Ill-being | Well-being | Ill-being | |||||
| C_14_8 | Resourceful | G_12_8 | Neuroprotection | 1.29E-03 | 0.01 | 0.01 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_10_7 | Resourceful | G_12_8 | Neuroprotection | 2.79E-03 | 0.41 | 0 | 0.09 | 0.03 | 0.41 | 0.03 |
| C_10_7 | Resourceful | G_33_11 | Self-control | 3.68E-03 | 0.41 | 0 | 0.26 | 0.07 | 0.41 | 0.07 |
| C_10_6i | Resourceful | G_33_19 | Res-RNA | 4.33E-03 | 0.03 | 0.38 | 0.09 | 0.12 | 0.09 | 0.38 |
| C_14_8 | Resourceful | G_11_4 | Inositol signaling | 4.86E-03 | 0.01 | 0.01 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_4_4 | Organized | G_11_4 | Inositol signaling | 1.26E-11 | 0.01 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_3_1 | Organized | G_11_4 | Inositol signaling | 7.18E-09 | 0 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_5_1 | Organized | G_11_4 | Inositol signaling | 2.19E-06 | 0.05 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_4_4 | Organized | G_12_8 | Neuroprotection | 9.79E-06 | 0.01 | 0 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_3_1 | Organized | G_12_8 | Neuroprotection | 1.38E-05 | 0 | 0 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_8_7 | Organized | G_11_4 | Inositol signaling | 2.78E-05 | 0.04 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_4_4 | Organized | G_10_1 | Learning/memory | 4.79E-05 | 0.01 | 0 | 0.07 | 0.06 | 0.07 | 0.06 |
| C_3_1 | Organized | G_10_1 | Learning/memory | 9.45E-05 | 0 | 0 | 0.07 | 0.06 | 0.07 | 0.06 |
| C_3_1 | Organized | G_21_4 | Org1-RNA | 1.70E-04 | 0 | 0 | 0.07 | 0.07 | 0.07 | 0.07 |
| C_4_4 | Organized | G_8_8 | Global inositol/chemokine pathways | 1.86E-04 | 0.01 | 0 | 0.08 | 0.07 | 0.08 | 0.07 |
| C_14_13 | Organized | G_24_6 | Neurogenesis | 1.86E-04 | 0.09 | 0 | 0.1 | 0.08 | 0.1 | 0.08 |
| C_4_4 | Organized | G_3_1 | Inositol calcium signaling | 3.38E-04 | 0.01 | 0 | 0.06 | 0.1 | 0.06 | 0.1 |
| C_9_8 | Organized | G_12_8 | Neuroprotection | 4.62E-04 | 0.12 | 0 | 0.09 | 0.03 | 0.12 | 0.03 |
| C_3_1 | Organized | G_3_1 | Inositol calcium signaling | 7.05E-04 | 0 | 0 | 0.06 | 0.1 | 0.06 | 0.1 |
| C_7_7 | Organized | G_11_4 | Inositol signaling | 7.17E-04 | 0.07 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_5_1 | Organized | G_12_8 | Neuroprotection | 7.58E-04 | 0.05 | 0 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_14_13 | Organized | G_12_8 | Neuroprotection | 8.50E-04 | 0.09 | 0 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_14_13 | Organized | G_23_19 | Org2-RNA | 1.00E-03 | 0.09 | 0 | 0.08 | 0.03 | 0.09 | 0.03 |
| C_5_1 | Organized | G_10_1 | Learning/memory | 1.09E-03 | 0.05 | 0 | 0.07 | 0.06 | 0.07 | 0.06 |
| C_3_1 | Organized | G_8_8 | Global inositol/chemokine pathways | 1.12E-03 | 0 | 0 | 0.08 | 0.07 | 0.08 | 0.07 |
| C_7_7 | Organized | G_17_14 | Dep-RNA | 1.32E-03 | 0.07 | 0 | 0.09 | 0.15 | 0.09 | 0.15 |
| C_15_1i | Organized | G_36_29 | Electron transport | 1.66E-03 | 0 | 0.79 | 0.08 | 0.48 | 0.08 | 0.79 |
| C_5_1 | Organized | G_8_8 | Global inositol/chemokine pathways | 2.07E-03 | 0.05 | 0 | 0.08 | 0.07 | 0.08 | 0.07 |
| C_14_13 | Organized | G_11_4 | Inositol signaling | 2.33E-03 | 0.09 | 0 | 0.07 | 0.04 | 0.09 | 0.04 |
| C_9_1i | Organized | G_38_10 | Org5-RNA | 2.34E-03 | 0 | 0.02 | 0.15 | 0.19 | 0.15 | 0.19 |
| C_7_5i | Organized | G_35_12 | Org4-RNA | 2.43E-03 | 0.5 | 0.06 | 0.16 | 0.09 | 0.5 | 0.09 |
| C_7_7 | Organized | G_12_8 | Neuroprotection | 2.50E-03 | 0.07 | 0 | 0.09 | 0.03 | 0.09 | 0.03 |
| C_5_1 | Organized | G_17_14 | Dep-RNA | 3.00E-03 | 0.05 | 0 | 0.09 | 0.15 | 0.09 | 0.15 |
| C_6_5 | Organized | G_11_4 | Inositol signaling | 3.04E-03 | 0.07 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_12_9 | Organized | G_7_3 | Neurogenesis | 3.13E-03 | 0.54 | 0 | 0.17 | 0.36 | 0.54 | 0.36 |
| C_8_7 | Organized | G_10_1 | Learning/memory | 3.54E-03 | 0.04 | 0 | 0.07 | 0.06 | 0.07 | 0.06 |
| C_4_4 | Organized | G_24_6 | Neurogenesis | 3.63E-03 | 0.01 | 0 | 0.1 | 0.08 | 0.1 | 0.08 |
| C_14_9 | Organized | G_31_8 | Neurotrophin | 3.65E-03 | 0.02 | 0.29 | 0.09 | 0.54 | 0.09 | 0.54 |
| C_14_9 | Organized | G_7_3 | Neurogenesis | 3.66E-03 | 0.02 | 0.29 | 0.17 | 0.36 | 0.17 | 0.36 |
| C_9_6 | Organized | G_27_25 | Org3-RNA | 3.84E-03 | 0.11 | 0.02 | 0.11 | 0.07 | 0.11 | 0.07 |
| C_8_7 | Organized | G_8_8 | Global inositol/chemokine pathways | 3.99E-03 | 0.04 | 0 | 0.08 | 0.07 | 0.08 | 0.07 |
| C_12_9 | Organized | G_9_8 | Neuroregulation | 4.96E-03 | 0.54 | 0 | 0.17 | 0.12 | 0.54 | 0.12 |
| C_3_3 | Creative | G_7_3 | Neurogenesis | 1.22E-06 | 0.92 | 0 | 0.17 | 0.36 | 0.92 | 0.36 |
| C_3_3 | Creative | G_5_1 | CDK neuroplasticity | 2.00E-06 | 0.92 | 0 | 0.17 | 0.4 | 0.92 | 0.4 |
| C_15_5 | Creative | G_3_2 | PAK-neuroprotection | 6.63E-06 | 0.72 | 0.03 | 0.18 | 0.24 | 0.72 | 0.24 |
| C_4_3 | Creative | G_20_2 | Enhanced memory | 1.13E-05 | 0.97 | 0 | 0.24 | 0.12 | 0.97 | 0.12 |
| C_14_1 | Creative | G_7_3 | Neurogenesis | 2.80E-05 | 0.25 | 0.11 | 0.17 | 0.36 | 0.25 | 0.36 |
| C_11_3 | Creative | G_33_15 | ERK-neurodevelopment | 3.99E-05 | 0.97 | 0.03 | 0.27 | 0.23 | 0.97 | 0.23 |
| C_8_8 | Creative | G_20_2 | Enhanced memory | 6.49E-05 | 1 | 0 | 0.24 | 0.12 | 1 | 0.12 |
| C_3_3 | Creative | G_20_2 | Enhanced memory | 9.26E-05 | 0.92 | 0 | 0.24 | 0.12 | 0.92 | 0.12 |
| C_5_5 | Creative | G_20_2 | Enhanced memory | 1.41E-04 | 1 | 0 | 0.24 | 0.12 | 1 | 0.12 |
| C_4_3 | Creative | G_33_15 | ERK-neurodevelopment | 1.65E-04 | 0.97 | 0 | 0.27 | 0.23 | 0.97 | 0.23 |
| C_5_5 | Creative | G_33_15 | ERK-neurodevelopment | 1.78E-04 | 1 | 0 | 0.27 | 0.23 | 1 | 0.23 |
| C_12_7 | Creative | G_33_15 | ERK-neurodevelopment | 3.21E-04 | 0.9 | 0.04 | 0.27 | 0.23 | 0.9 | 0.23 |
| C_4_3 | Creative | G_7_3 | Neurogenesis | 3.65E-04 | 0.97 | 0 | 0.17 | 0.36 | 0.97 | 0.36 |
| C_5_5 | Creative | G_7_3 | Neurogenesis | 4.21E-04 | 1 | 0 | 0.17 | 0.36 | 1 | 0.36 |
| C_6_1 | Creative | G_33_15 | ERK-neurodevelopment | 5.02E-04 | 1 | 0 | 0.27 | 0.23 | 1 | 0.23 |
| C_5_5 | Creative | G_19_5 | DARPP320-Neuroplasticity | 5.30E-04 | 1 | 0 | 0.16 | 0.22 | 1 | 0.22 |
| C_3_3 | Creative | G_19_5 | DARPP320-neuroplasticity | 7.66E-04 | 0.92 | 0 | 0.16 | 0.22 | 0.92 | 0.22 |
| C_3_3 | Creative | G_33_15 | ERK-neurodevelopment | 8.46E-04 | 0.92 | 0 | 0.27 | 0.23 | 0.92 | 0.23 |
| C_4_3 | Creative | G_12_1 | Episodic learning | 9.12E-04 | 0.97 | 0 | 0.2 | 0.06 | 0.97 | 0.06 |
| C_7_2 | Creative | G_33_15 | ERK-Neurodevelopment | 9.82E-04 | 0.98 | 0 | 0.27 | 0.23 | 0.98 | 0.23 |
| C_7_2 | Creative | G_36_27 | Aging regulation | 1.18E-03 | 0.98 | 0 | 0.33 | 0.22 | 0.98 | 0.22 |
| C_13_1 | Creative | G_20_2 | Enhanced memory | 1.23E-03 | 0.9 | 0.02 | 0.24 | 0.12 | 0.9 | 0.12 |
| C_13_1 | Creative | G_33_15 | ERK-neurodevelopment | 1.44E-03 | 0.9 | 0.02 | 0.27 | 0.23 | 0.9 | 0.23 |
| C_3_3 | Creative | G_12_1 | Episodic learning | 1.59E-03 | 0.92 | 0 | 0.2 | 0.06 | 0.92 | 0.06 |
| C_12_7 | Creative | G_12_1 | Episodic learning | 2.21E-03 | 0.9 | 0.04 | 0.2 | 0.06 | 0.9 | 0.06 |
| C_3_3 | Creative | G_9_8 | Neuroregulation | 2.27E-03 | 0.92 | 0 | 0.17 | 0.12 | 0.92 | 0.12 |
| C_3_3 | Creative | G_28_11 | Sensory transduction | 3.14E-03 | 0.92 | 0 | 0.22 | 0.06 | 0.92 | 0.06 |
| C_13_1 | Creative | G_28_11 | Sensory transduction | 3.17E-03 | 0.9 | 0.02 | 0.22 | 0.06 | 0.9 | 0.06 |
| C_4_3 | Creative | G_9_8 | Neuroregulation | 3.32E-03 | 0.97 | 0 | 0.17 | 0.12 | 0.97 | 0.12 |
| C_5_5 | Creative | G_12_1 | Episodic learning | 3.32E-03 | 1 | 0 | 0.2 | 0.06 | 1 | 0.06 |
| C_9_2i | Creative | G_34_13 | CREB-Episodic learning | 4.05E-03 | 0.05 | 0.2 | 0.05 | 0.29 | 0.05 | 0.29 |
| C_12_7 | Creative | G_7_3 | Neurogenesis | 4.10E-03 | 0.9 | 0.04 | 0.17 | 0.36 | 0.9 | 0.36 |
| C_12_7 | Creative | G_19_5 | DARPP320-Neuroplasticity | 4.22E-03 | 0.9 | 0.04 | 0.16 | 0.22 | 0.9 | 0.22 |
| C_11_3 | Creative | G_9_8 | Neuroregulation | 4.24E-03 | 0.97 | 0.03 | 0.17 | 0.12 | 0.97 | 0.12 |
| C_15_7 | Dependent | G_11_4 | Inositol signaling | 1.80E-06 | 0.03 | 0.02 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_12_6 | Dependent | G_31_8 | Neurotrophin | 8.93E-06 | 0.09 | 0.41 | 0.09 | 0.54 | 0.09 | 0.54 |
| C_12_6 | Dependent | G_41_33 | GPCR neuroplasticity | 1.18E-05 | 0.09 | 0.41 | 0.11 | 0.21 | 0.11 | 0.41 |
| C_15_13 | Dependent | G_31_8 | Neurotrophin | 6.14E-05 | 0 | 0.79 | 0.09 | 0.54 | 0.09 | 0.79 |
| C_4_2 | Dependent | G_28_15 | Histone methylation | 6.90E-05 | 0 | 0.45 | 0.08 | 0.38 | 0.08 | 0.45 |
| C_9_5 | Dependent | G_7_2 | GPCR dysregulation | 1.01E-04 | 0 | 0.26 | 0.09 | 0.23 | 0.09 | 0.26 |
| C_15_7 | Dependent | G_8_8 | Global inositol/chemokine pathways | 2.03E-04 | 0.03 | 0.02 | 0.08 | 0.07 | 0.08 | 0.07 |
| C_15_13 | Dependent | G_28_15 | Histone methylation | 2.92E-04 | 0 | 0.79 | 0.08 | 0.38 | 0.08 | 0.79 |
| C_4_2 | Dependent | G_5_1 | CDK neuroplasticity | 3.98E-04 | 0 | 0.45 | 0.17 | 0.4 | 0.17 | 0.45 |
| C_14_5 | Dependent | G_7_7 | Olfaction | 8.92E-04 | 0 | 0.29 | 0.03 | 0.1 | 0.03 | 0.29 |
| C_15_7 | Dependent | G_17_14 | Dep-RNA | 1.01E-03 | 0.03 | 0.02 | 0.09 | 0.15 | 0.09 | 0.15 |
| C_6_3 | Dependent | G_17_14 | Dep-RNA | 1.09E-03 | 0 | 0.32 | 0.09 | 0.15 | 0.09 | 0.32 |
| C_12_6 | Dependent | G_7_3 | Neurogenesis | 1.21E-03 | 0.09 | 0.41 | 0.17 | 0.36 | 0.17 | 0.41 |
| C_5_3 | Dependent | G_5_1 | CDK neuroplasticity | 1.43E-03 | 0.02 | 0.29 | 0.17 | 0.4 | 0.17 | 0.4 |
| C_15_13 | Dependent | G_5_1 | CDK neuroplasticity | 1.83E-03 | 0 | 0.79 | 0.17 | 0.4 | 0.17 | 0.79 |
| C_5_3 | Dependent | G_7_3 | Neurogenesis | 2.32E-03 | 0.02 | 0.29 | 0.17 | 0.36 | 0.17 | 0.36 |
| C_9_5 | Dependent | G_5_1 | CDK neuroplasticity | 2.63E-03 | 0 | 0.26 | 0.17 | 0.4 | 0.17 | 0.4 |
| C_4_2 | Dependent | G_7_3 | Neurogenesis | 2.66E-03 | 0 | 0.45 | 0.17 | 0.36 | 0.17 | 0.45 |
| C_6_3 | Dependent | G_7_7 | Olfaction | 2.73E-03 | 0 | 0.32 | 0.03 | 0.1 | 0.03 | 0.32 |
| C_4_2 | Dependent | G_31_8 | Neurotrophin | 2.93E-03 | 0 | 0.45 | 0.09 | 0.54 | 0.09 | 0.54 |
| C_6_3 | Dependent | G_22_6 | Blood-brain barrier | 3.40E-03 | 0 | 0.32 | 0.08 | 0.16 | 0.08 | 0.32 |
| C_4_2 | Dependent | G_41_33 | GPCR neuroplasticity | 3.44E-03 | 0 | 0.45 | 0.11 | 0.21 | 0.11 | 0.45 |
| C_7_4 | Dependent | G_5_1 | CDK neuroplasticity | 3.56E-03 | 0 | 0.74 | 0.17 | 0.4 | 0.17 | 0.74 |
| C_14_5 | Dependent | G_28_15 | Histone methylation | 3.73E-03 | 0 | 0.29 | 0.08 | 0.38 | 0.08 | 0.38 |
| C_3_2 | Apathetic | G_5_1 | CDK neuroplasticity | 6.13E-10 | 0 | 1 | 0.17 | 0.4 | 0.17 | 1 |
| C_3_2 | Apathetic | G_7_3 | Neurogenesis | 4.61E-08 | 0 | 1 | 0.17 | 0.36 | 0.17 | 1 |
| C_3_2 | Apathetic | G_28_15 | Histone methylation | 2.32E-05 | 0 | 1 | 0.08 | 0.38 | 0.08 | 1 |
| C_9_3i | Apathetic | G_26_14 | Glucose transport | 3.12E-04 | 0 | 1 | 0.09 | 0.24 | 0.09 | 1 |
| C_3_2 | Apathetic | G_7_2 | GPCR dysregulation | 4.18E-04 | 0 | 1 | 0.09 | 0.23 | 0.09 | 1 |
| C_10_2 | Apathetic | G_11_4 | Inositol signaling | 4.25E-04 | 0.01 | 0 | 0.07 | 0.04 | 0.07 | 0.04 |
| C_12_4i | Apathetic | G_35_4 | O-linked glycosylation | 4.30E-04 | 0.03 | 0.53 | 0.05 | 0.24 | 0.05 | 0.53 |
| C_11_4 | Apathetic | G_16_9 | Olfactory signaling | 5.78E-04 | 0 | 0.28 | 0.08 | 0.17 | 0.08 | 0.28 |
| C_7_3i | Apathetic | G_36_29 | Electron transport | 5.96E-04 | 0 | 1 | 0.08 | 0.48 | 0.08 | 1 |
| C_10_8 | Apathetic | G_5_1 | CDK neuroplasticity | 6.43E-04 | 0 | 0.79 | 0.17 | 0.4 | 0.17 | 0.79 |
| C_14_7i | Apathetic | G_36_29 | Electron transport | 7.85E-04 | 0 | 1 | 0.08 | 0.48 | 0.08 | 1 |
| C_11_10i | Apathetic | G_36_29 | Electron transport | 8.39E-04 | 0.03 | 0.5 | 0.08 | 0.48 | 0.08 | 0.5 |
| C_11_6i | Apathetic | G_20_3 | Fatty acid oxidation | 1.06E-03 | 0 | 0.71 | 0.03 | 0.33 | 0.03 | 0.71 |
| C_10_8 | Apathetic | G_31_8 | Neurotrophin | 1.21E-03 | 0 | 0.79 | 0.09 | 0.54 | 0.09 | 0.79 |
| C_15_15i | Apathetic | G_41_40 | Apha-RNA | 1.61E-03 | 0 | 0.3 | 0.09 | 0.03 | 0.09 | 0.3 |
| C_14_11 | Apathetic | G_28_15 | Histone methylation | 2.13E-03 | 0 | 0.47 | 0.08 | 0.38 | 0.08 | 0.47 |
| C_3_2 | Apathetic | G_40_26 | Dopamine-feedback | 2.41E-03 | 0 | 1 | 0.08 | 0.36 | 0.08 | 1 |
| C_10_2 | Apathetic | G_9_3 | Pyrimidine metabolism | 2.60E-03 | 0.01 | 0 | 0.12 | 0.04 | 0.12 | 0.04 |
| C_13_3i | Apathetic | G_26_14 | Glucose transport | 2.67E-03 | 0 | 0.25 | 0.09 | 0.24 | 0.09 | 0.25 |
| C_8_6i | Apathetic | G_36_29 | Electron transport | 2.69E-03 | 0 | 1 | 0.08 | 0.48 | 0.08 | 1 |
| C_10_8 | Apathetic | G_19_9 | Aurora-B | 3.25E-03 | 0 | 0.79 | 0.1 | 0.4 | 0.1 | 0.79 |
| C_10_8 | Apathetic | G_7_3 | Neurogenesis | 3.47E-03 | 0 | 0.79 | 0.17 | 0.36 | 0.17 | 0.79 |
| C_10_8 | Apathetic | G_23_2 | Biogenic synthesis | 3.56E-03 | 0 | 0.79 | 0.05 | 0.29 | 0.05 | 0.79 |
| C_11_6i | Apathetic | G_36_29 | Electron transport | 3.88E-03 | 0 | 0.71 | 0.08 | 0.48 | 0.08 | 0.71 |
| C_12_5 | Apathetic | G_7_2 | GPCR dysregulation | 3.99E-03 | 0 | 0.09 | 0.09 | 0.23 | 0.09 | 0.23 |
| C_10_2 | Apathetic | G_10_1 | Learning/memory | 4.03E-03 | 0.01 | 0 | 0.07 | 0.06 | 0.07 | 0.06 |
| C_8_3 | Apathetic | G_21_3 | Cellular Senescence | 4.17E-03 | 0 | 0.64 | 0.1 | 0.23 | 0.1 | 0.64 |
| C_14_3i | Apathetic | G_26_14 | Glucose transport | 4.43E-03 | 0.06 | 0.38 | 0.09 | 0.24 | 0.09 | 0.38 |
Association is measured by Fisher's exact test (hypergeometric). Probabilities of well-being and ill-being are given for subjects in the character sets, the SNP sets, and subjects identified in both jointly. iIndicates character sets that are more specific than their parental sets, which are also selected
Description of the five character profiles (supersets) and composite character sets identified by PGMRA from profiles of TCI subscales (Y = yes)
| Char sets | Supersets | Name | sd1 | sd2 | sd3 | sd4 | sd5 | co1 | co2 | co3 | co4 | co5 | st1 | st2 | st3 | Lsd1 | Lsd2 | Lsd3 | Lsd4 | Lsd5 | Lco1 | Lco2 | Lco3 | Lco4 | Lco5 | Lst1 | Lst2 | Lst3 | #S | Well Being | Ill Being |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C_14_8 | 1 | Resourceful | Y | Y | Y | 79 | 0.01 | 0.01 | |||||||||||||||||||||||
| C_10_7 | 1 | Y | Y | Y | Y | 102 | 0.41 | 0 | |||||||||||||||||||||||
| C_10_6 | 1 | Y | Y | Y | Y | 33 | 0.03 | 0.38 | |||||||||||||||||||||||
| C_14_13 | 2 | Organized | Y | Y | Y | Y | Y | Y | Y | 92 | 0.09 | 0 | |||||||||||||||||||
| C_14_9 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | 42 | 0.02 | 0.29 | |||||||||||||||||||
| C_9_8 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 72 | 0.12 | 0 | |||||||||||||||
| C_12_9 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | 41 | 0.54 | 0 | |||||||||||||||||||
| C_6_5 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 56 | 0.07 | 0 | |||||||||||||||
| C_8_7 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 161 | 0.04 | 0 | ||||||||||||||
| C_5_1 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 169 | 0.05 | 0 | ||||||||||||||
| C_3_1 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 293 | 0 | 0 | ||||||||||||||
| C_4_4 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 190 | 0.01 | 0 | ||||||||||||||
| C_7_7 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 101 | 0.07 | 0 | |||||||||||||||
| C_9_6 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 61 | 0.11 | 0.02 | ||||||||||||||
| C_7_5 | 2 | Y | Y | Y | Y | Y | 34 | 0.5 | 0.06 | ||||||||||||||||||||||
| C_9_1 | 2 | Y | Y | Y | Y | Y | Y | Y | Y | Y | 46 | 0 | 0.02 | ||||||||||||||||||
| C_15_5 | 3 | Creative | Y | Y | 100 | 0.72 | 0.03 | ||||||||||||||||||||||||
| C_12_7 | 3 | Y | Y | 52 | 0.9 | 0.04 | |||||||||||||||||||||||||
| C_11_3 | 3 | Y | Y | Y | 34 | 0.97 | 0.03 | ||||||||||||||||||||||||
| C_13_1 | 3 | Y | Y | Y | 42 | 0.9 | 0.02 | ||||||||||||||||||||||||
| C_14_1 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | 28 | 0.25 | 0.11 | |||||||||||||||||||
| C_7_2 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | 66 | 0.98 | 0 | ||||||||||||||||||
| C_8_8 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 39 | 1 | 0 | ||||||||||||||||
| C_4_3 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 72 | 0.97 | 0 | ||||||||||||||||
| C_5_5 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 73 | 1 | 0 | ||||||||||||||||
| C_6_1 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 32 | 1 | 0 | ||||||||||||||||
| C_3_3 | 3 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 135 | 0.92 | 0 | ||||||||||||||
| C_9_2 | 3 | Y | Y | Y | Y | Y | Y | 4 | 0.05 | 0.2 | |||||||||||||||||||||
| C_15_7 | 4 | Dependent | Y | Y | 121 | 0.03 | 0.02 | ||||||||||||||||||||||||
| C_14_5 | 4 | Y | Y | Y | 55 | 0 | 0.29 | ||||||||||||||||||||||||
| C_15_13 | 4 | Y | Y | Y | 29 | 0 | 0.79 | ||||||||||||||||||||||||
| C_12_6 | 4 | Y | Y | Y | Y | Y | Y | 44 | 0.09 | 0.41 | |||||||||||||||||||||
| C_4_2 | 4 | Y | Y | Y | Y | Y | Y | Y | 40 | 0 | 0.45 | ||||||||||||||||||||
| C_7_4 | 4 | Y | Y | Y | Y | Y | Y | Y | 23 | 0 | 0.74 | ||||||||||||||||||||
| C_5_3 | 4 | Y | Y | Y | Y | Y | Y | Y | Y | Y | 48 | 0.02 | 0.29 | ||||||||||||||||||
| C_6_3 | 4 | Y | Y | Y | Y | Y | Y | Y | Y | Y | 37 | 0 | 0.32 | ||||||||||||||||||
| C_9_5 | 4 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 31 | 0 | 0.26 | ||||||||||||||||
| C_10_2 | 5 | Apathetic | Y | Y | Y | 116 | 0.01 | 0 | |||||||||||||||||||||||
| C_11_4 | 5 | Y | Y | Y | 50 | 0 | 0.28 | ||||||||||||||||||||||||
| C_8_3 | 5 | Y | Y | Y | Y | 39 | 0 | 0.64 | |||||||||||||||||||||||
| C_14_11 | 5 | Y | Y | Y | Y | Y | Y | 62 | 0 | 0.47 | |||||||||||||||||||||
| C_10_8 | 5 | Y | Y | Y | Y | Y | Y | Y | Y | Y | 33 | 0 | 0.79 | ||||||||||||||||||
| C_3_2 | 5 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 53 | 0 | 1 | |||||||||||||||||
| C_12_5 | 5 | Y | Y | Y | Y | Y | Y | Y | 22 | 0 | 0.09 | ||||||||||||||||||||
| C_14_7 | 5 | Y | Y | Y | Y | Y | 4 | 0 | 1 | ||||||||||||||||||||||
| C_13_3 | 5 | Y | Y | Y | Y | Y | 4 | 0 | 0.25 | ||||||||||||||||||||||
| C_14_3 | 5 | Y | 32 | 0.06 | 0.38 | ||||||||||||||||||||||||||
| C_11_10 | 5 | Y | Y | Y | Y | Y | Y | Y | Y | 38 | 0.03 | 0.5 | |||||||||||||||||||
| C_15_1 | 5 | Y | Y | Y | 21 | 0.14 | 0.52 | ||||||||||||||||||||||||
| C_7_3 | 5 | Y | Y | 15 | 0 | 1 | |||||||||||||||||||||||||
| C_8_6 | 5 | Y | Y | Y | 7 | 0 | 1 | ||||||||||||||||||||||||
| C_9_3 | 5 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 7 | 0 | 1 | ||||||||||||||||
| C_15_15 | 5 | Y | Y | Y | 33 | 0 | 0.3 | ||||||||||||||||||||||||
| C_11_6 | 5 | Y | Y | 28 | 0 | 0.71 | |||||||||||||||||||||||||
| C_12_4 | 5 | Y | Y | Y | Y | Y | Y | 34 | 0.03 | 0.53 | |||||||||||||||||||||
| Resourceful | Y | Y | Y | ||||||||||||||||||||||||||||
| Organized | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | ||||||||||||||||||
| Creative | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | ||||||||||||||||||
| Dependent | Y | Y | Y | Y | Y | Y | Y | Y | Y | ||||||||||||||||||||||
| Apathetic | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
TCI subscales are indicated self-directedness (sd1–sd5), cooperativeness (co1–co5), and self-transcendence (st1–st3). Subscale values were divided by median split into high and low scores (distinguished by L before the low scores). The number of subjects in each character set is specified (#S). The probabilities of well-being and ill-being are shown for subjects in each character set (see also Supplementary Table S2)